News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 20, 2009, 09:15 ET

Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com), a developer of oral drug delivery systems, announced today that its poster...

Sep 09, 2009, 09:15 ET

Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog

Oramed Pharmaceticals, Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that it has received approval from the...

Sep 03, 2009, 09:15 ET

Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference

Oramed Pharmaceuticals Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today...

Aug 25, 2009, 09:15 ET

Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, today announced that it is the...

Aug 18, 2009, 09:15 ET

Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England

Oramed Pharmaceuticals, Inc. (OTC: ORMP) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that Oramed's...

Aug 04, 2009, 08:45 ET

Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com), a developer of oral delivery systems, today reported that its wholly owned...

Jul 21, 2009, 07:00 ET

Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com), a developer of alternative drug delivery systems, today reported positive...

Jun 10, 2009, 07:09 ET

Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced that Oramed was chosen to...

May 05, 2009, 07:20 ET

Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule

Oramed Pharmaceuticals, Inc. (OTC: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced that Phase 2b clinical trials...

Mar 25, 2009, 08:40 ET

Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that it has been...

Feb 04, 2009, 07:30 ET

Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, announced today that it has concluded a proof of...

Nov 14, 2008, 08:00 ET

Oramed Pharmaceuticals Presents Results of Oral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of proprietary drug delivery systems, presented the results...

Jul 10, 2008, 01:00 ET

Nobel Prize Winner Professor Avram Hershko Named to Oramed Pharmaceuticals Scientific Advisory Board

JERUSALEM, July 10 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery...

Jun 04, 2008, 01:00 ET

Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)

JERUSALEM, June 4 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery...

Aug 14, 2007, 01:00 ET

Oramed Pharmaceuticals Successfully Completes Phase 1A Trials

JERUSALEM, Israel, August 14 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP), a developer of peptide delivery systems, is...

Aug 06, 2007, 01:00 ET

Oramed Pharmaceuticals Completes $2 Million in Financing

JERUSALEM, Israel, August 6 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc.(OTCBB: ORMP), a leading developer of the oral insulin gel...

Jun 19, 2007, 01:00 ET

Oramed Pharmaceuticals Signs Agreement with Encorium Group to Commence Investigational New Drug Application

JERUSALEM and WAYNE, Pa., June 19 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc.(OTC Bulletin Board: ORMP), an Israeli company focused...

Jun 06, 2007, 01:00 ET

Exclusive Interview with Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.CEOcast.com

JERUSALEM, June 6 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTC Bulletin Board: ORMP ; FTSE: OJU) invites everybody to join Nadav...

May 08, 2007, 01:00 ET

Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials

JERUSALEM, May 8 /PRNewswire/ -- After much anticipation, Oramed Pharmaceuticals (OTC Bulletin Board: ORMP; FTSE: OJU) is excited to announce...

May 01, 2007, 01:00 ET

Oramed Pharmaceuticals Expands Product Line With the Addition of Two New Provisional Patents in the Intellectual Property Portfolio

JERUSALEM, May 1 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTC Bulletin Board: ORMP; FTSE: OJU) is pleased to announce the...